ArticleProteome science2009

Development of reverse phase protein microarrays for the validation of clusterin, a mid-abundant blood biomarker.

Adriana Aguilar-Mahecha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.